Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 10 of 2295 results
Sort by: relevance publication year

Hypoglycemia in patients with type 2 diabetes using concomitant exenatide BID and long-acting insulin therapy

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: Manjiri D. Pawaskar | Amy L. Blickensderfer | Byron J. Hoogwerf | Ralph Quimbo | Rolin Wade

Clinical outcome of hypertension management

JOURNAL ARTICLE published January 2008 in Journal of Medical Economics

Authors: Vivian WY Lee | Tony HW Chan | Tina TL Ko | Kenneth KC Lee | Brian Tomlinson

Economic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn’s disease in Argentina, Brazil, Colombia, and Mexico

JOURNAL ARTICLE published 1 December 2016 in Journal of Medical Economics

Authors: Namita Tundia | Paulo Gustavo Kotze | Jorge Rojas Serrano | Mirhelen Mendes de Abreu | Martha Skup | Dendy Macaulay | James Signorovitch | Leonardo Chaves | Jingdong Chao | Yanjun Bao

Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: Michael S. Broder | Eunice Y. Chang | Tanya G.K. Bentley | Timothy Juday | Jonathan Uy

Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis

JOURNAL ARTICLE published 2 July 2016 in Journal of Medical Economics

Authors: W. Weng | Y. Liang | E. S. Kimball | T. Hobbs | S. Kong | B. Sakurada | J. Bouchard

Estimated cost savings associated with the use of valsartan in heart failure in a large US health plan

JOURNAL ARTICLE published January 2007 in Journal of Medical Economics

Authors: Dean G Smith | Feride Frech-Tamas | William Randle | Ronald Preblick

Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data

JOURNAL ARTICLE published 4 March 2018 in Journal of Medical Economics

Authors: Joseph A. Sierra | Mona Shah | Max S. Gill | Zachery Flores | Hiten Chawla | Francine R. Kaufman | Robert Vigersky

Annual patient and caregiver burden of oncology clinic visits for granulocyte-colony stimulating factor therapy in the US

JOURNAL ARTICLE published 3 May 2016 in Journal of Medical Economics

Authors: J. Mark Stephens | Xiaoyan Li | Maureen Reiner | Spiros Tzivelekis

Updated trends in US brand-name and generic drug competition

JOURNAL ARTICLE published 1 September 2016 in Journal of Medical Economics

Research funded by Pharmaceutical Research and Manufacturers of America Foundation (N/A (see 3rd party support disclosure))

Authors: Henry Grabowski | Genia Long | Richard Mortimer | Ani Boyo

Health and economic impact of PHiD-CV in Canada and the UK: a Markov modelling exercise

JOURNAL ARTICLE published January 2012 in Journal of Medical Economics

Authors: Gerhart Knerer | Afisi Ismaila | David Pearce

Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: Yonghua Jing | Stephen S. Johnston | Robert Fowler | John A. Bates | Robert A. Forbes | Tony Hebden

Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study

JOURNAL ARTICLE published 31 December 2024 in Journal of Medical Economics

Authors: Wai Chee Kuan | Kok Han Chee | Sazzli Kasim | Ka Keat Lim | Juman Abdulelah Dujaili | Kenneth Kwing-Chin Lee | Siew Li Teoh

Switching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting

JOURNAL ARTICLE published April 2014 in Journal of Medical Economics

Authors: Brian Meissner | Digisha Trivedi | Min You | Lisa Rosenblatt

Time since diagnosis, treatment pathways and current pain status: a retrospective assessment in a back pain population

JOURNAL ARTICLE published May 2013 in Journal of Medical Economics

Authors: Paul C. Langley | Hiltrud Liedgens

A new model to evaluate the long-term cost effectiveness of orphan and highly specialised drugs following listing on the Australian Pharmaceutical Benefits Scheme: the Bosentan Patient Registry

JOURNAL ARTICLE published January 2008 in Journal of Medical Economics

Authors: AJ Owen | J Spinks | A Meehan | T Robb | M Hardy | D Kwasha | J Wlodarczyk | CM Reid

Relationship between incidence of fracture and health-related quality-of-life in metastatic breast cancer patients with bone metastases

JOURNAL ARTICLE published February 2013 in Journal of Medical Economics

Authors: Mark S. Walker | Paul J. E. Miller | Madhav Namjoshi | Arthur C. Houts | Edward J. Stepanski | Lee S. Schwartzberg

Budget impact analysis of adjunctive therapy with lacosamide for partial-onset epileptic seizures in Belgium

JOURNAL ARTICLE published January 2011 in Journal of Medical Economics

Authors: Steven Simoens

Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression

JOURNAL ARTICLE published 31 December 2024 in Journal of Medical Economics

Authors: Samantha Meltzer-Brody | Margaret E. Gerbasi | Catherine Mak | Youssef Toubouti | Sarah Smith | Neil Roskell | Robin Tan | Shih-Yin (Sharon) Chen | Kristina M. Deligiannidis

Economic value and cost-effectiveness of biventricular versus right ventricular pacing: results from the BLOCK-HF study

JOURNAL ARTICLE published 3 October 2019 in Journal of Medical Economics

Authors: Eugene S. Chung | Martin G. St. John Sutton | Stuart Mealing | Manpreet K. Sidhu | Amie Padhiar | Stelios I. Tsintzos | Xiaoxiao Lu | Koen J. P. Verhees | Amy A. Lautenbach | Anne B. Curtis

Predictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C

JOURNAL ARTICLE published 2 April 2016 in Journal of Medical Economics

Authors: Joyce LaMori | Neeta Tandon | François Laliberté | Guillaume Germain | Dominic Pilon | Patrick Lefebvre | Avinash Prabhakar